V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015948 | 160008944 | 1.57 | 51.4 | Palliative (P) | 2020-01-29 | 2020-02-26 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 101198999 |
| 160016067 | 160008945 | null | 90.4 | Palliative (P) | 2018-07-26 | 2018-07-29 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100042257 |
| 160016294 | 160008946 | 1.72 | 89 | Palliative (P) | 2018-08-09 | 2018-08-09 | DOXORUBICIN | 02 | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 100012257 |
| 160016351 | 160008947 | 1.75 | 84 | Curative (C) | 2012-11-01 | 2012-11-07 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100433377 |
| 160016392 | 160008948 | 1.51 | 57.2 | Disease modification (D) | 2018-03-28 | 2018-04-22 | MELPHALAN | Y | N | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101645454 |
| 160016614 | 160008949 | 1.68 | 55.2 | Palliative (P) | 2016-05-12 | 2016-05-31 | ETOP 13-18 BEAT-meso Trial | null | N | DOXORUBICIN + OLARATUMAB | 101439583 |
| 160016680 | 160008951 | 1.71 | 69.2 | Palliative (P) | 2017-12-01 | 2017-12-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101791071 |
| 160016734 | 160008952 | 1.74 | 69.7 | null | 2018-08-24 | 2018-09-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100068510 |
| 160016886 | 160008953 | 1.63 | 44.7 | Palliative (P) | null | 2017-09-19 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 101764625 |
| 160017049 | 160008954 | 1.83 | 84.7 | Neo-adjuvant (N) | 2017-11-18 | 2017-12-30 | ETOPOSIDE + RITUXIMAB | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101696667 |
| 160017106 | 160008956 | 1.71 | 105.9 | Palliative (P) | 2018-10-10 | 2018-10-25 | Doxorubicin 75mg/m2 | null | N | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 100451101 |
| 160017273 | 160008957 | 1.84 | 123.5 | Palliative (P) | null | 2018-05-06 | Vinorelbine (oral) | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100423693 |
| 160017276 | 160008958 | 1.71 | 92.2 | null | 2019-04-15 | 2019-04-21 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + OLARATUMAB | 100469645 |
| 160017330 | 160008959 | null | null | Palliative (P) | 2019-01-10 | 2019-01-18 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101791368 |
| 160017342 | 160008960 | 1.8 | 101 | Palliative (P) | 2019-10-22 | 2019-10-26 | BEP 5 Day | 02 | N | VINCRISTINE | 100659435 |
| 160017345 | 160008961 | 1.57 | 52.8 | null | 2017-04-13 | 2017-04-13 | DOXORUBICIN | 02 | null | EW EUROEWING 2012 ARM B VDC | 101752473 |
| 160017371 | 160008962 | 1.74 | 73.1 | Adjuvant (A) | 2017-03-25 | 2017-04-12 | null | null | N | DOXORUBICIN + IFOSFAMIDE | 101632066 |
| 160017413 | 160008963 | 1.86 | 71.8 | Curative (C) | 2016-05-28 | 2016-05-28 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100878063 |
| 160017512 | 160008964 | 1.7 | 84.35 | Palliative (P) | 2018-09-21 | 2018-10-06 | Carboplatin AUC 2 - 5 | 02 | N | IDARUBICIN | 101539516 |
| 160007409 | 160008967 | 1.72 | 97.2 | Neo-adjuvant (N) | 2018-03-31 | 2018-04-08 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101332352 |
| 160007785 | 160008968 | 1.52 | 70.4 | Palliative (P) | 2019-11-29 | 2019-12-30 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101236512 |
| 160009060 | 160008969 | null | null | Palliative (P) | 2017-06-21 | 2017-06-23 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100676140 |
| 160009398 | 160008971 | 1.71 | 55.7 | null | 2016-07-26 | 2016-08-06 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | DOXORUBICIN | 101361877 |
| 160009742 | 160008972 | 1.72 | 87.4 | Palliative (P) | 2018-02-09 | 2018-02-16 | EW EuroEwing 2012 Arm B VDC | null | N | PACLITAXEL | 101683016 |
| 160012676 | 160008974 | 1.74 | 73.1 | null | 2018-10-14 | 2018-10-17 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101571023 |
| 160013461 | 160008975 | 1.71 | 75.8 | Curative (C) | 2018-07-04 | 2018-07-15 | LIPOSOMAL DOXORUBICIN | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101452805 |
| 160014139 | 160008977 | 1.68 | 45 | null | 2018-03-28 | 2018-03-30 | null | 02 | null | FEC | 100716659 |
| 160014160 | 160008978 | 1.88 | 72 | Palliative (P) | 2019-03-22 | 2019-03-22 | Enzalutamide | 2 | N | DOXORUBICIN + IFOSFAMIDE | 101205055 |
| 160014586 | 160008979 | 1.75 | 90.3 | Neo-adjuvant (N) | 2018-10-15 | 2018-10-15 | ETOP 13-18 BEAT-meso Trial | 02 | null | TRIAL UNSPECIFIED | 100657445 |
| 160016567 | 160008980 | 1.77 | 96 | Palliative (P) | 2020-01-03 | 2020-01-13 | Doxorubicin + Ifosfamide | N | N | IVADO | 101213411 |
| 160003820 | 160009908 | null | null | null | 2019-08-08 | 2019-08-09 | null | N | null | CARBOPLATIN + PEMETREXED | 100165673 |
| 160003844 | 160009911 | 1.68 | 71 | Neo-adjuvant (N) | null | 2013-07-13 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 101617379 |
| 160003863 | 160009916 | null | 67.8 | Palliative (P) | 2020-01-14 | 2020-01-29 | Carboplatin + Pemetrexed | 02 | N | CARBOPLATIN + PEMETREXED | 101496139 |
| 160003867 | 160009918 | null | null | null | null | 2020-05-06 | null | N | null | CARBOPLATIN + PEMETREXED | 100442235 |
| 160003874 | 160009919 | 1.67 | 80.9 | Palliative (P) | null | 2018-01-06 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100625618 |
| 160003883 | 160009924 | null | 81.2 | Palliative (P) | null | 2019-11-12 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100137418 |
| 160003893 | 160009927 | null | null | null | null | 2018-03-31 | null | null | null | CARBOPLATIN + PEMETREXED | 101571538 |
| 160003954 | 160009937 | null | null | null | null | 2018-05-01 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101166863 |
| 160003955 | 160009938 | null | 57.9 | Adjuvant (A) | 2018-04-25 | 2018-04-28 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 101051548 |
| 160003959 | 160009939 | 1.65 | 100 | Palliative (P) | null | 2016-11-18 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100093545 |
| 160003966 | 160009940 | null | null | null | null | 2018-04-02 | null | null | null | CARBOPLATIN + PEMETREXED | 100428369 |
| 160003985 | 160009946 | null | null | null | null | 2018-12-03 | null | null | null | CARBOPLATIN + PEMETREXED | 101441503 |
| 160003989 | 160009947 | null | null | null | null | 2016-04-03 | null | null | null | CARBOPLATIN + PEMETREXED | 101769781 |
| 160003994 | 160009950 | null | null | null | null | 2019-01-16 | null | null | null | CARBOPLATIN + PEMETREXED | 100069706 |
| 160004013 | 160009953 | null | null | null | null | 2016-11-30 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101469809 |
| 160004020 | 160009955 | null | 76.99 | Palliative (P) | null | 2017-07-04 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100771892 |
| 160004022 | 160009956 | null | 87.8 | Palliative (P) | null | 2018-11-03 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 101497272 |
| 160004026 | 160009958 | null | null | null | null | 2015-11-20 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100983901 |
| 160004067 | 160009968 | null | null | null | null | 2016-06-01 | null | null | null | CARBOPLATIN + PEMETREXED | 100050366 |
| 160004077 | 160009970 | null | 74.4 | Palliative (P) | 2017-03-17 | 2017-04-08 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100164495 |